| Literature DB >> 16763676 |
John S Carey1, David Laffan, Colin Thomson, Mike T Williams.
Abstract
The purpose of this perspective is to indicate the range of chemistries used in the manufacture of drug candidate molecules and to highlight certain gaps in current technologies. To do this a survey was carried out of chemical syntheses within the Process Chemistry R&D departments of GlaxoSmithKline, AstraZeneca and Pfizer.Mesh：
Substances：
Year: 2006 PMID： 16763676 DOI： 10.1039/b602413k
Source DB: PubMed Journal: Org Biomol Chem ISSN： 1477-0520 Impact factor: 3.876